|
|
|
Volumn 27, Issue 5 SUPPL. 10, 2000, Pages 88-90
|
|
Trimetrexate as a biochemical modulator of 5-flourouracil and leucovorin in colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
TRIMETREXATE;
ALLERGY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG HYPERSENSITIVITY;
DRUG MECHANISM;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
META ANALYSIS;
NAUSEA;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VOMITING;
ANTIDOTES;
ANTIMETABOLITES, ANTINEOPLASTIC;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
FLUOROURACIL;
FOLIC ACID ANTAGONISTS;
HUMANS;
LEUCOVORIN;
TRIMETREXATE;
|
|
EID: 0033790793
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (10)
|
